VLA has 2 posters including a presentation again on MITCI at ASCO on the 5th June.
Hopefully, we'll get a bit more of an update on the progress of both trials.
Abstract 3014 Activity of a novel immunotherapy combination of intralesional CoxsackievirusA21 and systemic ipilimumab in advanced melanoma patients previously treated with anti-PD1 blockade therapy.
Poster Board: #109
Discussed at the Poster Discussion Session on Monday, June 5, 2017, 4:45 PM - 6:00 PM, at Hall D1
Brendan D. Curti - First Author
Providence Cancer Center and Earle A. Chiles Research Institute
Abstract TPS3108 Keynote-200 phase 1b: A novel combination study of intravenously delivered coxsackievirus A21 and pembrolizumab in advanced cancer patients.
Poster Board: #194b
Hardev S. Pandha, MD, PhD - First Author
University of Surrey